Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


AcelRx Pharmaceuticals 

575 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-216-3500 Fax: 650-216-6500




 Company News
AcelRx Pharmaceuticals (ACRX) To Participate At Two Upcoming Investor Events 2/20/2015 1:32:24 PM
AcelRx Pharmaceuticals (ACRX) To Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/4/2015 11:09:10 AM
AcelRx Pharmaceuticals (ACRX) Receives CE Mark Approval For Zalviso 12/2/2014 10:31:16 AM
AcelRx Pharmaceuticals (ACRX) To Participate In Four Upcoming Investor Events 11/20/2014 9:27:14 AM
AcelRx Pharmaceuticals (ACRX) Announces Zalviso™ Sublingual Sufentanil Data Presentation At The American Society Of Regional Anesthesia And Pain Medicine Meeting 11/13/2014 9:05:13 AM
AcelRx Pharmaceuticals (ACRX) Reports Third Quarter 2014 Financial Results 11/11/2014 7:42:02 AM
AcelRx Pharmaceuticals (ACRX) Receives International Standards Organization (ISO) 13485:2003 Certification Of Its Quality Management System 11/10/2014 9:59:46 AM
AcelRx Pharmaceuticals (ACRX) To Participate In Two Upcoming Investor Events 11/7/2014 8:29:36 AM
AcelRx Pharmaceuticals (ACRX) To Hold Third Quarter Financial Results Conference Call And Webcast On Monday, November 10, 2014 11/6/2014 8:37:34 AM
AcelRx Pharmaceuticals (ACRX) CEO Steps Down As Company Plots 2nd Try At Drug-Device Approval 11/5/2014 10:12:27 AM